Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 18.81
(9.49%)
CNY 18.81
(9.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 452.94 Million CNY | 30.64% |
| 2022 | 346.69 Million CNY | -16.01% |
| 2021 | 412.78 Million CNY | 3.66% |
| 2020 | 398.19 Million CNY | 104.88% |
| 2019 | 194.35 Million CNY | 63.36% |
| 2018 | 118.97 Million CNY | 13.43% |
| 2017 | 104.89 Million CNY | -21.0% |
| 2016 | 132.78 Million CNY | 20.37% |
| 2015 | 110.31 Million CNY | 306.62% |
| 2014 | 27.12 Million CNY | -82.15% |
| 2013 | 151.95 Million CNY | 5.47% |
| 2012 | 144.07 Million CNY | 26.28% |
| 2011 | 114.09 Million CNY | 38.23% |
| 2010 | 82.53 Million CNY | 34.21% |
| 2009 | 61.5 Million CNY | 41.96% |
| 2008 | 43.32 Million CNY | 17.21% |
| 2007 | 36.96 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 85.59 Million CNY | 19.6% |
| 2024 Q1 | 87.57 Million CNY | -51.14% |
| 2024 Q2 | 71.56 Million CNY | -18.27% |
| 2023 Q4 | 179.24 Million CNY | 87.83% |
| 2023 FY | 452.94 Million CNY | 30.64% |
| 2023 Q1 | 80.82 Million CNY | -28.9% |
| 2023 Q2 | 97.44 Million CNY | 20.57% |
| 2023 Q3 | 95.42 Million CNY | -2.07% |
| 2022 FY | 346.69 Million CNY | -16.01% |
| 2022 Q4 | 113.67 Million CNY | 21.99% |
| 2022 Q3 | 93.18 Million CNY | 37.8% |
| 2022 Q2 | 67.62 Million CNY | -6.34% |
| 2022 Q1 | 72.2 Million CNY | -40.12% |
| 2021 Q3 | 88.6 Million CNY | 1.57% |
| 2021 Q4 | 120.59 Million CNY | 36.1% |
| 2021 Q2 | 87.23 Million CNY | -25.03% |
| 2021 FY | 412.78 Million CNY | 3.66% |
| 2021 Q1 | 116.35 Million CNY | -20.27% |
| 2020 Q4 | 145.92 Million CNY | 39.02% |
| 2020 FY | 398.19 Million CNY | 104.88% |
| 2020 Q1 | 73.12 Million CNY | 47.12% |
| 2020 Q2 | 74.16 Million CNY | 1.42% |
| 2020 Q3 | 104.97 Million CNY | 41.53% |
| 2019 Q1 | 43.29 Million CNY | 232.15% |
| 2019 Q4 | 49.7 Million CNY | -14.76% |
| 2019 FY | 194.35 Million CNY | 63.36% |
| 2019 Q3 | 58.31 Million CNY | 35.45% |
| 2019 Q2 | 43.04 Million CNY | -0.56% |
| 2018 Q3 | 37.44 Million CNY | 24.75% |
| 2018 FY | 118.97 Million CNY | 13.43% |
| 2018 Q1 | 38.48 Million CNY | 1457.88% |
| 2018 Q2 | 30.01 Million CNY | -22.02% |
| 2018 Q4 | 13.03 Million CNY | -65.19% |
| 2017 Q4 | 2.47 Million CNY | -94.66% |
| 2017 FY | 104.89 Million CNY | -21.0% |
| 2017 Q1 | 31.5 Million CNY | -6.39% |
| 2017 Q2 | 24.68 Million CNY | -21.63% |
| 2017 Q3 | 46.23 Million CNY | 87.3% |
| 2016 FY | 132.78 Million CNY | 20.37% |
| 2016 Q4 | 33.64 Million CNY | -30.59% |
| 2016 Q3 | 48.48 Million CNY | 80.57% |
| 2016 Q2 | 26.84 Million CNY | 12.8% |
| 2016 Q1 | 23.8 Million CNY | -23.24% |
| 2015 Q2 | 21.51 Million CNY | -16.11% |
| 2015 FY | 110.31 Million CNY | 306.62% |
| 2015 Q3 | 32.14 Million CNY | 49.4% |
| 2015 Q4 | 31 Million CNY | -3.53% |
| 2015 Q1 | 25.64 Million CNY | 310.64% |
| 2014 Q1 | 18.51 Million CNY | -66.55% |
| 2014 FY | 27.12 Million CNY | -82.15% |
| 2014 Q3 | 7.84 Million CNY | -39.41% |
| 2014 Q2 | 12.94 Million CNY | -30.05% |
| 2014 Q4 | -12.17 Million CNY | -255.2% |
| 2013 FY | 151.95 Million CNY | 5.47% |
| 2013 Q1 | 30.13 Million CNY | -42.59% |
| 2013 Q3 | 26.56 Million CNY | -33.47% |
| 2013 Q4 | 55.33 Million CNY | 108.3% |
| 2013 Q2 | 39.93 Million CNY | 32.52% |
| 2012 FY | 144.07 Million CNY | 26.28% |
| 2012 Q1 | 24.72 Million CNY | -15.88% |
| 2012 Q2 | 41.85 Million CNY | 69.32% |
| 2012 Q3 | 25.01 Million CNY | -40.25% |
| 2012 Q4 | 52.48 Million CNY | 109.85% |
| 2011 Q2 | 34.58 Million CNY | 54.33% |
| 2011 Q4 | 29.38 Million CNY | 6.03% |
| 2011 Q1 | 22.4 Million CNY | 8.1% |
| 2011 FY | 114.09 Million CNY | 38.23% |
| 2011 Q3 | 27.71 Million CNY | -19.84% |
| 2010 Q1 | 19.56 Million CNY | 7.51% |
| 2010 FY | 82.53 Million CNY | 34.21% |
| 2010 Q4 | 20.72 Million CNY | 9.68% |
| 2010 Q3 | 18.89 Million CNY | -19.05% |
| 2010 Q2 | 23.34 Million CNY | 19.29% |
| 2009 FY | 61.5 Million CNY | 41.96% |
| 2009 Q3 | 16.02 Million CNY | 0.0% |
| 2009 Q4 | 18.2 Million CNY | 13.57% |
| 2008 FY | 43.32 Million CNY | 17.21% |
| 2007 FY | 36.96 Million CNY | 0.0% |